Michael S Mulvihill
Overview
Explore the profile of Michael S Mulvihill including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
536
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ezekian J, Mulvihill M, Ezekian B, Cox M, Kirmani S, Hill K
Cardiol Young
. 2021 Aug;
31(8):1228-1237.
PMID: 34429175
Background: Increased risk donors in paediatric heart transplantation have characteristics that may increase the risk of infectious disease transmission despite negative serologic testing. However, the risk of disease transmission is...
2.
Choi A, Jawitz O, Raman V, Mulvihill M, Halpern S, Barac Y, et al.
J Thorac Cardiovasc Surg
. 2020 Jun;
161(2):458-466.e3.
PMID: 32563573
Objective: Despite growing evidence of comparable outcomes in recipients of donation after circulatory death and donation after brain death donor lungs, donation after circulatory death allografts continue to be underused...
3.
Choi A, Mulvihill M, Lee H, Zhao C, Kuchibhatla M, Schroder J, et al.
JAMA Cardiol
. 2020 Apr;
5(6):660-668.
PMID: 32293647
Importance: Under the current Centers for Medicare & Medicaid Services guidelines, there is incentivization to optimize posttransplant outcomes regardless of mortality among patients on the waitlist and transplant rates; few...
4.
Mulvihill M, Lee H, Weber J, Choi A, Cox M, Yerokun B, et al.
J Heart Lung Transplant
. 2020 Feb;
39(4):353-362.
PMID: 32029400
Background: Lung transplantation offers a survival benefit for patients with end-stage lung disease. When suitable donors are identified, centers must accept or decline the offer for a matched candidate on...
5.
Ezekian B, Schroder P, Mulvihill M, Barbas A, Collins B, Freischlag K, et al.
J Am Soc Nephrol
. 2019 Oct;
30(12):2399-2411.
PMID: 31658991
Background: Patients with broad HLA sensitization have poor access to donor organs, high mortality while waiting for kidney transplant, and inferior graft survival. Although desensitization strategies permit transplantation lowering of...
6.
Nasir B, Mulvihill M, Barac Y, Bishawi M, Cox M, Megna D, et al.
J Heart Lung Transplant
. 2019 Sep;
38(9):939-948.
PMID: 31495410
Background: The optimal transplant strategy for patients with end-stage lung disease complicated by secondary pulmonary hypertension (PH) is controversial. The aim of this study is to define the role of...
7.
Osho A, Bishawi M, Mulvihill M, Axtell A, Hirji S, Spencer P, et al.
Ann Thorac Surg
. 2019 Aug;
109(1):218-224.
PMID: 31470009
Background: The clinical response to postoperative complications after lung transplantation (LTx) may contribute to mortality differences among transplantation centers. The ability to avoid mortality after a complication-failure to rescue (FTR)-may...
8.
Jawitz O, Raman V, Barac Y, Mulvihill M, Moore C, Choi A, et al.
Ann Thorac Surg
. 2019 Jul;
108(5):1519-1526.
PMID: 31271742
Background: Donor brain death duration (BDD) may impact posttransplant graft function and survival in lung transplant. Methods: We queried the 2007 to 2018 United Network for Organ Sharing Registry for...
9.
Samy K, Gao Q, Davis R, Song M, Fitch Z, Mulvihill M, et al.
Xenotransplantation
. 2019 Jun;
26(6):e12540.
PMID: 31219218
Background: Membrane cofactor protein CD46 attenuates the complement cascade by facilitating cleavage of C3b and C4b. In solid organ xenotransplantation, organs expressing CD46 have been shown to resist hyperacute rejection....
10.
Moore C, Cox M, Mulvihill M, Klapper J, DAmico T, Hartwig M
J Thorac Cardiovasc Surg
. 2019 May;
158(2):570-578.e3.
PMID: 31056356
Objective: The objective of this project was to assess the best measure for postoperative outcomes by comparing 30-day and 90-day mortality rates after surgery for non-small cell lung cancer using...